Cheng-Lun Ku

Title: Innovations of Cheng-Lun Ku in Immunotherapy

Introduction

Cheng-Lun Ku is a prominent inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on antibodies. With a total of 4 patents to his name, his research focuses on developing therapeutic solutions for various medical conditions.

Latest Patents

One of Cheng-Lun Ku's latest patents is titled "Anti-interferon gamma antibodies and uses thereof." This patent provides an anti-INF-γ antibody, along with a composition that includes the antibody and its pharmaceutical application in treating IFN-γ mediated syndrome. Another notable patent is "Antibodies to granulocyte-macrophage colony stimulating factor and uses thereof." This invention discloses anti-GM-CSF antibodies that can bind to human GM-CSF and block its biological activities. It also includes pharmaceutical compositions comprising these antibodies and their therapeutic and diagnostic uses.

Career Highlights

Cheng-Lun Ku is associated with Elixiron Immunotherapeutics (Hong Kong) Limited, where he continues to advance his research in immunotherapy. His work has the potential to impact the treatment of various diseases, showcasing his dedication to improving healthcare through innovation.

Collaborations

Cheng-Lun Ku collaborates with notable colleagues, including Han-Po Shih and Jing-Ya Ding. Their combined expertise contributes to the success of their research initiatives.

Conclusion

Cheng-Lun Ku's innovative work in the field of immunotherapy highlights his commitment to advancing medical science. His patents reflect significant advancements that could lead to improved treatments for patients.